source
- AstraZeneca pulls EU filing for antibody as CHMP backs Gazyvaro in lupusAstraZeneca has withdrawn its European marketing application for a monoclonal antibody in a subset of amyloidosis patients. The candidate had previously failed two late-stage studies in a broader p…Endpoints · 1h ago↗ source
- Eli Lilly’s Mounjaro and Merck’s oral PCSK9 inhibitor win FDA nod amid string of cardiovascular trial setbacksThe cardiovascular drug development landscape entered the American Heart Association’s Scientific Sessions with a mix of optimism and disappointment. Recent months have seen several late‑stage tria…